Description

NSE lists further equity shares issued under ESOP and QIP by Dr. Agarwal's Health Care, Axis Bank, Biocon, CG Power, Cyient, Five-Star Business Finance, ITC, Kanpur Plastipack, Kfin Technologies, Sterlite Technologies, and Tracxn Technologies effective January 20, 2026.

Summary

NSE has approved the listing of further equity shares issued by 11 companies effective January 20, 2026. The securities include equity shares allotted under Employee Stock Option Plans (ESOP) and Qualified Institutional Placement (QIP). The circular provides ISIN codes, distinctive number ranges, face values, and allotment details for each company’s further issue.

Key Points

  • 11 companies have been approved for listing of further equity issues on NSE Capital Market segment
  • Effective date: January 20, 2026
  • Most issues are under ESOP schemes with face values ranging from Re. 1 to Rs. 5
  • Biocon Limited issued 112,664,585 equity shares under QIP at Rs. 368.35 per share
  • All securities are pari passu with existing shares
  • Market lot size is 1 for all securities
  • No lock-in period applicable for any of the listed securities

Securities Details

Dr. Agarwal’s Health Care Limited (AGARWALEYE)

  • 337,504 equity shares of Re. 1 each under ESOP
  • Allotment date: January 6, 2026
  • ISIN: INE943P01029

Axis Bank Limited (AXISBANK)

  • 88,198 equity shares of Rs. 2 each under ESOP
  • Allotment date: January 13, 2026
  • ISIN: INE238A01034

Biocon Limited (BIOCON)

  • 112,664,585 equity shares of Rs. 5 each under QIP
  • Issue price: Rs. 368.35
  • Allotment date: January 14, 2026
  • ISIN: INE376G01013

CG Power and Industrial Solutions Limited (CGPOWER)

  • 10,000 equity shares of Rs. 2 each under ESOP
  • Allotment date: January 7, 2026
  • ISIN: INE067A01029

Cyient Limited (CYIENT)

  • 12,442 equity shares of Rs. 5 each under ESOP
  • Allotment date: January 8, 2026
  • ISIN: INE136B01020

Five-Star Business Finance Limited (FIVESTAR)

  • Equity shares of Re. 1 each under ESOP
  • ISIN: INE128S01021

Regulatory Changes

No regulatory changes introduced. This circular is issued in pursuance of existing regulations:

  • Regulation 3.1.1 of NSE (Capital Market) Trading Regulations Part A
  • Regulation 2.5.5 of NSE (Capital Market) Trading Regulations Part A

Compliance Requirements

  • Trading members must use designated security codes for trading these securities
  • Trading must be conducted in specified lot sizes (market lot of 1 for all securities)
  • Securities to be identified only by designated codes on the trading system

Important Dates

  • Circular Date: January 19, 2026
  • Effective Date: January 20, 2026
  • Allotment Dates: Range from January 6, 2026 to January 14, 2026

Impact Assessment

This is a routine administrative circular with minimal market impact. The listing of further issues represents normal corporate actions related to employee compensation (ESOP) and capital raising (QIP). The largest issue is Biocon’s QIP of 112.66 million shares, which may have modest dilution impact on existing shareholders. No trading restrictions or lock-in periods apply, allowing immediate liquidity for these securities.

Impact Justification

Routine listing of further equity issues under ESOP and QIP schemes. No change to trading regulations or market structure. Minimal impact on overall market capitalization.